For: | Wang W, Guo MN, Li N, Pang DQ, Wu JH. Glutamine deprivation impairs function of infiltrating CD8+ T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis. World J Gastrointest Oncol 2022; 14(6): 1124-1140 [PMID: 35949216 DOI: 10.4251/wjgo.v14.i6.1124] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i6/1124.htm |
Number | Citing Articles |
1 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2022; 14(9): 1887-1891 doi: 10.4251/wjgo.v14.i9.1887
|
2 |
Vijay Kumar, John H. Stewart. Immunometabolic reprogramming, another cancer hallmark. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1125874
|
3 |
Liming Liao, Huilin Xu, Yuhan Zhao, Xiaofeng Zheng. Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies. Frontiers of Medicine 2023; 17(5): 805 doi: 10.1007/s11684-023-1025-7
|
4 |
Jian Lin, Dongning Rao, Mao Zhang, Qiang Gao. Metabolic reprogramming in the tumor microenvironment of liver cancer. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01527-8
|
5 |
Barbara Janota, Barbara Szymanek. The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC). Cancers 2024; 16(5): 1030 doi: 10.3390/cancers16051030
|
6 |
Maria Pires Pacheco, Jimmy Ji, Tessy Prohaska, María Moscardó García, Thomas Sauter. scFASTCORMICS: A Contextualization Algorithm to Reconstruct Metabolic Multi-Cell Population Models from Single-Cell RNAseq Data. Metabolites 2022; 12(12): 1211 doi: 10.3390/metabo12121211
|
7 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2022; 14(9): 1886 doi: 10.4251/wjgo.v14.i9.1886
|
8 |
Kyra Laubach, Tolga Turan, Rebecca Mathew, Julie Wilsbacher, John Engelhardt, Josue Samayoa. Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment. Cancer Drug Resistance 2023; 6(3): 611 doi: 10.20517/cdr.2023.60
|